HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C E Clarke Selected Research

Lisuride

1/2000Lisuride for levodopa-induced complications in Parkinson's disease.
1/2000Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C E Clarke Research Topics

Disease

35Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2000
13Dyskinesias (Dyskinesia)
12/2005 - 01/2000
4Nausea
10/2004 - 01/2000
3Confusion (Bewilderment)
12/2003 - 01/2001
2Dementia (Dementias)
11/2010 - 11/2002
2Headache (Headaches)
06/2010 - 05/2001
2Hallucinations (Hallucination)
12/2003 - 01/2003
2Parkinsonian Disorders (Parkinsonism)
11/2001 - 11/2000
2Multiple System Atrophy
11/2001 - 11/2000
2Dysarthria (Spastic Dysarthria)
01/2001 - 01/2001
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
11/2010
1Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
06/2009
1Obesity
06/2009
1Cardiac Arrhythmias (Arrythmia)
06/2006
1Constipation
10/2004
1Neuroleptic Malignant Syndrome
03/2004
1Tremor (Tremors)
01/2003
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
11/2001
1Corticobasal Degeneration
11/2001
1Hypokinesia (Bradykinesia)
05/2001
1Dizziness (Lightheadedness)
05/2001
1Vomiting
05/2001
1Deglutition Disorders (Dysphagia)
01/2001
1Speech Disorders (Cluttering)
01/2001

Drug/Important Bio-Agent (IBA)

21Levodopa (L Dopa)FDA LinkGeneric
01/2022 - 01/2000
8Dopamine Agonists (Dopamine Agonist)IBA
01/2022 - 01/2000
5ropinirole (Requip)FDA LinkGeneric
01/2001 - 01/2000
4Bromocriptine (Parlodel)FDA LinkGeneric
01/2001 - 01/2000
3Pharmaceutical PreparationsIBA
10/2004 - 01/2001
2Tolcapone (Tasmar)FDA Link
10/2004 - 10/2004
2Catechol O-Methyltransferase InhibitorsIBA
10/2004 - 10/2004
2entacapone (Comtan)FDA Link
10/2004 - 10/2004
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2003 - 05/2001
2Amantadine (Aman)FDA LinkGeneric
01/2003 - 01/2003
2Protons (Proton)IBA
11/2001 - 11/2000
2CabergolineFDA LinkGeneric
01/2001 - 01/2001
2LisurideIBA
01/2000 - 01/2000
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
01/2022
1Monoamine Oxidase (MAO)IBA
01/2022
1LeptinIBA
06/2009
1CytokinesIBA
06/2009
1Ether (Diethyl Ether)IBA
06/2006
1Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
10/2004
1Fluvoxamine (Luvox)FDA LinkGeneric
12/2003
1Antidepressive Agents (Antidepressants)IBA
12/2003
1Amitriptyline (Elavil)FDA LinkGeneric
12/2003
1Antiviral Agents (Antivirals)IBA
01/2003
1Choline (Choline Chloride)IBA
11/2001
1CreatineIBA
11/2001
1N-acetylaspartate (N-acetyl aspartate)IBA
11/2001
1remacemideIBA
05/2001
1ApomorphineFDA Link
11/2000
1Dopamine (Intropin)FDA LinkGeneric
05/2000

Therapy/Procedure

26Therapeutics
01/2022 - 01/2000
3Language Therapy (Language Training)
05/2020 - 01/2001
3Drug Therapy (Chemotherapy)
11/2010 - 08/2001
2Occupational Therapy (Therapy, Occupational)
09/2009 - 01/2001
2Drug Tapering
01/2001 - 01/2000
1Complementary Therapies (Alternative Medicine)
06/2010
1Activities of Daily Living (ADL)
09/2009
1Physical Therapy Modalities (Physical Therapy Technique)
01/2001